Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 70951-71000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05644431
GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
N/ARecruiting
50 participants
Started: Jul 19, 2023 · Completed: Jan 15, 2028
1 condition1 sponsor1 location
NCT05864573
Study of ZGGS15 in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
22 participants
Started: Jul 19, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05964127
Peri-implantitis and Systemic Inflammation
NARecruiting
138 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05071222
Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)
PHASE1/PHASE2Recruiting
5 participants
Started: Jul 19, 2023 · Completed: Jul 19, 2041
1 condition1 sponsor1 location
NCT05916222
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
NARecruiting
40 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06279702
Serious Game Simulation and Comics in School Students
NAActive, not recruiting
54 participants
Started: Jul 19, 2023 · Completed: Jul 19, 2025
1 condition1 sponsor1 location
NCT05933577
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
PHASE3Active, not recruiting
1,089 participants
Started: Jul 19, 2023 · Completed: Sep 26, 2030
1 condition2 sponsors165 locations
NCT06879600
High-Flow Nasal Oxygen for Preoxygenation in Emergency Surgery Patients With Full Stomachs
NARecruiting
200 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2026
6 conditions3 sponsors1 location
NCT05943522
Asciminib RMP Study
N/ARecruiting
100 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor14 locations
NCT06002048
AI Ready and Exploratory Atlas for Diabetes Insights
N/AEnrolling by invitation
4,000 participants
Started: Jul 19, 2023 · Completed: Jan 1, 2027
1 condition2 sponsors3 locations
NCT06951126
CT Prediction for Transcatheter Tricuspid Interventions
N/ARecruiting
500 participants
Started: Jul 19, 2023 · Completed: Jun 1, 2030
2 conditions8 sponsors1 location
NCT05118490
Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients
PHASE4Recruiting
1,000 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2024
3 conditions2 sponsors4 locations
NCT05628350
Highly Processed Foods and Vascular Health
NAActive, not recruiting
17 participants
Started: Jul 19, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT07051863
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
N/ARecruiting
200 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2030
3 conditions1 sponsor1 location
NCT05804526
A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours
PHASE1/PHASE2Recruiting
82 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04915079
PRISM Race and Communication Pilot RCT
PHASE2Recruiting
60 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2024
4 conditions2 sponsors1 location
NCT06431100
a Single-arm, Single-center, Open Clinical Study
N/ARecruiting
10 participants
Started: Jul 19, 2023 · Completed: Nov 19, 2026
5 conditions1 sponsor1 location
NCT05924464
Group Preconception Care for Fertility Patients
NAActive, not recruiting
140 participants
Started: Jul 19, 2023 · Completed: Jun 30, 2027
1 condition3 sponsors1 location
NCT04937751
Markers of Infection and Resistance in Invasive Fusariosis
N/ARecruiting
150 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT05965661
A New 3D Virtual Reality-based Upper Limb Training to Improve Dexterity in Parkinson's Disease
NARecruiting
20 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06495697
Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus Bacteremia
N/ARecruiting
200 participants
Started: Jul 19, 2023 · Completed: Jul 19, 2024
1 condition1 sponsor1 location
NCT05843643
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
PHASE3Recruiting
1,000 participants
Started: Jul 19, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor364 locations
NCT07154784
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
PHASE2/PHASE3Enrolling by invitation
30 participants
Started: Jul 19, 2023 · Completed: Jun 30, 2027
2 conditions4 sponsors1 location
NCT05959512
Smoking Pattern and Influencing Factors in Hospitalized Patients
N/AActive, not recruiting
200 participants
Started: Jul 19, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05375162
Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)
NARecruiting
304 participants
Started: Jul 18, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT05783596
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
PHASE2Active, not recruiting
47 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2029
3 conditions2 sponsors4 locations
NCT05852691
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
PHASE2Active, not recruiting
83 participants
Started: Jul 18, 2023 · Completed: Dec 18, 2026
1 condition1 sponsor38 locations
NCT05980403
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma(RENMIN-237)
N/ARecruiting
300 participants
Started: Jul 18, 2023 · Completed: Dec 18, 2024
1 condition1 sponsor1 location
NCT04975516
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer
PHASE2Recruiting
54 participants
Started: Jul 18, 2023 · Completed: Jul 2, 2027
4 conditions1 sponsor1 location
NCT05467163
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation
NARecruiting
82 participants
Started: Jul 18, 2023 · Completed: Dec 25, 2026
3 conditions1 sponsor10 locations
NCT05986461
Spatially Transcriptomics Reveals Molecular Signatures in CRPS
N/ARecruiting
10 participants
Started: Jul 18, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06126705
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
EARLY_PHASE1Recruiting
60 participants
Started: Jul 18, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT06078852
Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients
NARecruiting
34 participants
Started: Jul 18, 2023 · Completed: Jul 30, 2026
2 conditions1 sponsor1 location
NCT06305104
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
PHASE2Recruiting
420 participants
Started: Jul 18, 2023 · Completed: Jun 30, 2024
1 condition7 sponsors6 locations
NCT05834556
Home-based Exercise for Frail Individuals Prior to Cardiac Surgery
NARecruiting
20 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2024
5 conditions1 sponsor1 location
NCT05801029
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
PHASE2Active, not recruiting
60 participants
Started: Jul 18, 2023 · Completed: Oct 1, 2027
1 condition2 sponsors29 locations
NCT05964205
Analysis of a Stepped-Wedge Implementation of the PT-PENCIL Tool
N/AActive, not recruiting
9,704 participants
Started: Jul 18, 2023 · Completed: Oct 30, 2025
1 condition2 sponsors1 location
NCT06030362
Probiotic Intervention Study
NARecruiting
100 participants
Started: Jul 18, 2023 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06968585
A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy
PHASE3Active, not recruiting
365 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06258863
Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery
N/AEnrolling by invitation
300 participants
Started: Jul 18, 2023 · Completed: Nov 18, 2025
1 condition1 sponsor1 location
NCT06003023
Congenital Heart Disease Physical Activity Lifestyle Study V.2
NARecruiting
144 participants
Started: Jul 18, 2023 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT05963828
Comprehensive Management of High-risk PopuLatIon of Stroke Based on Social Network
NARecruiting
720 participants
Started: Jul 18, 2023 · Completed: Jun 30, 2025
7 conditions1 sponsor1 location
NCT05010564
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
PHASE1Recruiting
38 participants
Started: Jul 18, 2023 · Completed: Mar 29, 2040
1 condition2 sponsors1 location
NCT05578287
RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer
PHASE2Recruiting
29 participants
Started: Jul 18, 2023 · Completed: Dec 25, 2025
1 condition1 sponsor1 location
NCT06853951
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
PHASE3Recruiting
30 participants
Started: Jul 18, 2023 · Completed: Jul 18, 2025
1 condition1 sponsor2 locations
NCT05927688
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
N/ARecruiting
352 participants
Started: Jul 18, 2023 · Completed: Jul 31, 2027
4 conditions1 sponsor1 location
NCT05933629
Community-based Implementation of Online EmReg
NARecruiting
50 participants
Started: Jul 18, 2023 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT05974904
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
N/ARecruiting
7,000 participants
Started: Jul 18, 2023 · Completed: Dec 28, 2026
3 conditions1 sponsor1 location
NCT05606991
The Effect of OSA on Brain Waste Clearance
NAEnrolling by invitation
38 participants
Started: Jul 18, 2023 · Completed: Apr 30, 2026
3 conditions2 sponsors1 location
NCT05954299
Vincere Biobank Research Protocol
N/ARecruiting
5,000 participants
Started: Jul 18, 2023 · Completed: Dec 31, 2038
1 condition1 sponsor1 location